(6 Oct 2015) Interview with Kim Popovits, CEO of Genomic Health, Inc., the healthcare company that performs the Oncotype DX diagnostic test for breast cancer recurrence. Find out more about AP Archive: http://www.aparchive.com/HowWeWork Twitter: https://twitter.com/AP_Archive Facebook: https://www.facebook.com/APArchives ​​ Instagram: https://www.instagram.com/APNews/ You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/c80c55380391449f9adff6c731fd4d45

Tag-uri: Facebook Instagram Twitter